Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,159.43
-15.1800-1.29%
Volume:1.67M
Turnover:1.93B
Market Cap:1.10T
PE:38.92
High:1,171.45
Open:1,168.04
Low:1,147.00
Close:1,174.61
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.71
T/O Rate:0.18%
Dividend:6.69
Dividend Rate:0.58%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:32.35
PE(LYR):50.52

Loading ...

CVS Health Corp: Co & Lilly Collaborating to Help Eligible Zepbound and Foundayo Patients More Easily Access Transparent Pricing

THOMSON REUTERS
·
Aug 05

European Shares Hover Near Record Highs as Earnings Offset Mideast Uncertainty

Reuters
·
Aug 05

Eli Lilly Raises Annual Revenue Forecast as GLP-1 Drugs Fuel Growth

Reuters
·
Aug 05

Novo CEO Looks to Speed up R&D as Share Drop Shows Gap with Lilly

Reuters
·
Aug 05

AMD, Walt Disney And 3 Stocks To Watch Heading Into Wednesday

Benzinga Earnings
·
Aug 05

Novo Nordisk Earnings Beat but Study Data, Wegovy Pill Sales Underwhelm

Dow Jones
·
Aug 05

Sandoz Gains on Strong Biosimilar Growth, Touts 'golden Decade'

Reuters
·
Aug 05

Suncoast Equity Management trims Eli Lilly position

TIPRANKS
·
Aug 05

Eli Lilly Could Swing $65.9 Billion After Earnings

Benzinga
·
Aug 05

How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings

Benzinga Earnings
·
Aug 04

Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly

MT Newswires Live
·
Aug 04

Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients

Reuters
·
Aug 04

Believe it is Medically Appropriate to Make Authentic Retatrutide Available Before FDA Approval for Patients Meeting Some Criteria -Lilly Spokesperson

THOMSON REUTERS
·
Aug 04

Eli Lilly tells Stat it will let more patients apply for retatrutide access

TIPRANKS
·
Aug 04

Movement Alert|Eli Lilly Falls 3.21% in Regular Trading, Pipeline Breakthrough Overshadowed by GLP-1 Growth Concerns and Sector Weakness

Market Focus
·
Aug 03

Eli Lilly Could Swing Over $76 Billion In Value After Earnings

Benzinga_recent_news
·
Aug 03

Lilly's Olomorasib Receives U.S. FDA's Breakthrough Therapy Designation for the Treatment of Previously Treated Kras G12c-Mutant Advanced Pancreatic Cancer

THOMSON REUTERS
·
Aug 03

Eli Lilly Stock Leads 3 Pharma Picks As Merger Talk Shakes Big Drugmakers

Simply Wall St.
·
Aug 03

Stock Markets Can't Rely on Tech to Power Gains Anymore

Dow Jones
·
Aug 03

Jobs Report; Palantir, AMD, SpaceX, and Eli Lilly Earnings Reports: What to Watch This Week

Dow Jones
·
Aug 03